Thierry Laugel

Pharmacist, Doctor of Pharmacology, Insead MBA. Thierry Laugel is Chairman of the Management Board of Kurma Partners.

After his thesis, Thierry was a scientific representative for 4 years of Fournier Laboratories in Japan when Lipanthyl was registered in Japan and research programs were set up with the company Grelan (Takeda group). After a stint at Insead, he joined Flamel Technologies as Director of Pharmaceutical R&D projects, after his IPO at Nasdaq.

Following this, he joined the investment world in 1998, first within the Caisse des Dépôts (CDC Innovation then within the PharmaVent project), then at AGF Private Equity where he supervised the investment team. health investment.